Loading…
Review of a three-year meticillin-resistant Staphylococcus aureus screening programme
Summary The Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH) implemented a seek and destroy (S&D) programme in 2006 to minimise meticillin-resistant Staphylococcus aureus (MRSA) colonisation and/or infection of patients. Using a phased introduction, all patient specialties were included...
Saved in:
| Published in: | The Journal of hospital infection 2011-06, Vol.78 (2), p.81-85 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c472t-bb4b46946256210d904bfe511d8f80223b1b1dcec19ff8172619f1ca4d36d0af3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c472t-bb4b46946256210d904bfe511d8f80223b1b1dcec19ff8172619f1ca4d36d0af3 |
| container_end_page | 85 |
| container_issue | 2 |
| container_start_page | 81 |
| container_title | The Journal of hospital infection |
| container_volume | 78 |
| creator | Collins, J Raza, M Ford, M Hall, L Brydon, S Gould, F.K |
| description | Summary The Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH) implemented a seek and destroy (S&D) programme in 2006 to minimise meticillin-resistant Staphylococcus aureus (MRSA) colonisation and/or infection of patients. Using a phased introduction, all patient specialties were included in the scheme by September 2008, well in advance of the mandatory Department of Health, England (DoH) requirement for all patients to be screened. NuTH screens nose, throat and perineum samples from approximately 15 000 patients per month using a chromogenic culture method, showing a mean MRSA prevalence of 2.4%. Provision of seven-day microbiology and infection control services ensured that the turnaround time to prescribing decolonisation therapy was |
| doi_str_mv | 10.1016/j.jhin.2011.02.012 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_872138530</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0195670111001046</els_id><sourcerecordid>872138530</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-bb4b46946256210d904bfe511d8f80223b1b1dcec19ff8172619f1ca4d36d0af3</originalsourceid><addsrcrecordid>eNqFkl-L1TAQxYMo7nX1C_ggfRGfWmfSJm1BBFn8BwuC6z6HNJ3sTW3Ta9Iq99ubcq8KPujThPA7M8k5w9hThAIB5cuhGPbOFxwQC-AFIL_HdihKnvO2bO-zHWArclkDXrBHMQ4AkO7FQ3bBUUAtsNmx28_03dGPbLaZzpZ9IMqPpEM20eKMG0fn80DRxUX7JbtZ9GF_HGczG7PGTK-BUokmqbzzd9khzHdBTxM9Zg-sHiM9OddLdvvu7ZerD_n1p_cfr95c56aq-ZJ3XdVVsq0kF5Ij9C1UnSWB2De2Ac7LDjvsDRlsrW2w5jId0OiqL2UP2paX7MWpb5r8baW4qMlFQ-OoPc1rVE3NsWxECf8nZV1zkfxJJD-RJswxBrLqENykw1EhqM13NajNd7X5roCr5HsSPTu3X7uJ-t-SX0Yn4PkZ0NHo0QbtjYt_uIrz9L06ca9OHCXbUjJBRePIG-pdILOofnb_fsfrv-QmRejSxK90pDjMa_ApEIUqJoG62TZkWxBEAIRKlj8BmbG18Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>867725093</pqid></control><display><type>article</type><title>Review of a three-year meticillin-resistant Staphylococcus aureus screening programme</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Collins, J ; Raza, M ; Ford, M ; Hall, L ; Brydon, S ; Gould, F.K</creator><creatorcontrib>Collins, J ; Raza, M ; Ford, M ; Hall, L ; Brydon, S ; Gould, F.K</creatorcontrib><description>Summary The Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH) implemented a seek and destroy (S&D) programme in 2006 to minimise meticillin-resistant Staphylococcus aureus (MRSA) colonisation and/or infection of patients. Using a phased introduction, all patient specialties were included in the scheme by September 2008, well in advance of the mandatory Department of Health, England (DoH) requirement for all patients to be screened. NuTH screens nose, throat and perineum samples from approximately 15 000 patients per month using a chromogenic culture method, showing a mean MRSA prevalence of 2.4%. Provision of seven-day microbiology and infection control services ensured that the turnaround time to prescribing decolonisation therapy was <24 h. Analysis of 168 073 results identified the necessity for inclusion of all three screening sites to maximise recovery of MRSA. Appraisal of the S&D policy demonstrated that MRSA detection rates did not increase despite an exponential increase in workload owing to mandatory inclusion of low risk areas in the screening programme. Review of data during a typical one-month period indicated that only seven day-case patients would not have been identified as MRSA carriers using our targeted S&D approach compared with the DoH universal screening. Detection of these additional patients incurred total laboratory costs of £20,000 and generated a further 4200 associated negative screens in one month alone. Our study indicates that a screening strategy based upon clinical risk is more pragmatic and more cost-effective than the universal programme currently required in England.</description><identifier>ISSN: 0195-6701</identifier><identifier>EISSN: 1532-2939</identifier><identifier>DOI: 10.1016/j.jhin.2011.02.012</identifier><identifier>PMID: 21507518</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Bacterial diseases ; Bacteriological Techniques ; Biological and medical sciences ; Carrier State - diagnosis ; Carrier State - epidemiology ; Carrier State - microbiology ; Chromogenic Compounds ; Culture Media ; England ; Hospitals, Teaching ; Human bacterial diseases ; Humans ; Infection Control - economics ; Infection Control - methods ; Infectious Disease ; Infectious diseases ; Mass Screening - economics ; Mass Screening - methods ; Medical sciences ; Methicillin-Resistant Staphylococcus aureus - isolation & purification ; Meticillin-resistant Staphylococcus aureus ; Nose - microbiology ; Nose, throat and perineum ; Perineum - microbiology ; Pharynx - microbiology ; Prevalence ; Program Evaluation ; Staphylococcal Infections - diagnosis ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - microbiology ; Staphylococcal infections, streptococcal infections, pneumococcal infections ; Staphylococcus aureus ; Targeted approach ; Universal screening</subject><ispartof>The Journal of hospital infection, 2011-06, Vol.78 (2), p.81-85</ispartof><rights>The Healthcare Infection Society</rights><rights>2011 The Healthcare Infection Society</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-bb4b46946256210d904bfe511d8f80223b1b1dcec19ff8172619f1ca4d36d0af3</citedby><cites>FETCH-LOGICAL-c472t-bb4b46946256210d904bfe511d8f80223b1b1dcec19ff8172619f1ca4d36d0af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24227267$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21507518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Collins, J</creatorcontrib><creatorcontrib>Raza, M</creatorcontrib><creatorcontrib>Ford, M</creatorcontrib><creatorcontrib>Hall, L</creatorcontrib><creatorcontrib>Brydon, S</creatorcontrib><creatorcontrib>Gould, F.K</creatorcontrib><title>Review of a three-year meticillin-resistant Staphylococcus aureus screening programme</title><title>The Journal of hospital infection</title><addtitle>J Hosp Infect</addtitle><description>Summary The Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH) implemented a seek and destroy (S&D) programme in 2006 to minimise meticillin-resistant Staphylococcus aureus (MRSA) colonisation and/or infection of patients. Using a phased introduction, all patient specialties were included in the scheme by September 2008, well in advance of the mandatory Department of Health, England (DoH) requirement for all patients to be screened. NuTH screens nose, throat and perineum samples from approximately 15 000 patients per month using a chromogenic culture method, showing a mean MRSA prevalence of 2.4%. Provision of seven-day microbiology and infection control services ensured that the turnaround time to prescribing decolonisation therapy was <24 h. Analysis of 168 073 results identified the necessity for inclusion of all three screening sites to maximise recovery of MRSA. Appraisal of the S&D policy demonstrated that MRSA detection rates did not increase despite an exponential increase in workload owing to mandatory inclusion of low risk areas in the screening programme. Review of data during a typical one-month period indicated that only seven day-case patients would not have been identified as MRSA carriers using our targeted S&D approach compared with the DoH universal screening. Detection of these additional patients incurred total laboratory costs of £20,000 and generated a further 4200 associated negative screens in one month alone. Our study indicates that a screening strategy based upon clinical risk is more pragmatic and more cost-effective than the universal programme currently required in England.</description><subject>Bacterial diseases</subject><subject>Bacteriological Techniques</subject><subject>Biological and medical sciences</subject><subject>Carrier State - diagnosis</subject><subject>Carrier State - epidemiology</subject><subject>Carrier State - microbiology</subject><subject>Chromogenic Compounds</subject><subject>Culture Media</subject><subject>England</subject><subject>Hospitals, Teaching</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infection Control - economics</subject><subject>Infection Control - methods</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Mass Screening - economics</subject><subject>Mass Screening - methods</subject><subject>Medical sciences</subject><subject>Methicillin-Resistant Staphylococcus aureus - isolation & purification</subject><subject>Meticillin-resistant Staphylococcus aureus</subject><subject>Nose - microbiology</subject><subject>Nose, throat and perineum</subject><subject>Perineum - microbiology</subject><subject>Pharynx - microbiology</subject><subject>Prevalence</subject><subject>Program Evaluation</subject><subject>Staphylococcal Infections - diagnosis</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><subject>Staphylococcus aureus</subject><subject>Targeted approach</subject><subject>Universal screening</subject><issn>0195-6701</issn><issn>1532-2939</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkl-L1TAQxYMo7nX1C_ggfRGfWmfSJm1BBFn8BwuC6z6HNJ3sTW3Ta9Iq99ubcq8KPujThPA7M8k5w9hThAIB5cuhGPbOFxwQC-AFIL_HdihKnvO2bO-zHWArclkDXrBHMQ4AkO7FQ3bBUUAtsNmx28_03dGPbLaZzpZ9IMqPpEM20eKMG0fn80DRxUX7JbtZ9GF_HGczG7PGTK-BUokmqbzzd9khzHdBTxM9Zg-sHiM9OddLdvvu7ZerD_n1p_cfr95c56aq-ZJ3XdVVsq0kF5Ij9C1UnSWB2De2Ac7LDjvsDRlsrW2w5jId0OiqL2UP2paX7MWpb5r8baW4qMlFQ-OoPc1rVE3NsWxECf8nZV1zkfxJJD-RJswxBrLqENykw1EhqM13NajNd7X5roCr5HsSPTu3X7uJ-t-SX0Yn4PkZ0NHo0QbtjYt_uIrz9L06ca9OHCXbUjJBRePIG-pdILOofnb_fsfrv-QmRejSxK90pDjMa_ApEIUqJoG62TZkWxBEAIRKlj8BmbG18Q</recordid><startdate>20110601</startdate><enddate>20110601</enddate><creator>Collins, J</creator><creator>Raza, M</creator><creator>Ford, M</creator><creator>Hall, L</creator><creator>Brydon, S</creator><creator>Gould, F.K</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope></search><sort><creationdate>20110601</creationdate><title>Review of a three-year meticillin-resistant Staphylococcus aureus screening programme</title><author>Collins, J ; Raza, M ; Ford, M ; Hall, L ; Brydon, S ; Gould, F.K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-bb4b46946256210d904bfe511d8f80223b1b1dcec19ff8172619f1ca4d36d0af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Bacterial diseases</topic><topic>Bacteriological Techniques</topic><topic>Biological and medical sciences</topic><topic>Carrier State - diagnosis</topic><topic>Carrier State - epidemiology</topic><topic>Carrier State - microbiology</topic><topic>Chromogenic Compounds</topic><topic>Culture Media</topic><topic>England</topic><topic>Hospitals, Teaching</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infection Control - economics</topic><topic>Infection Control - methods</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Mass Screening - economics</topic><topic>Mass Screening - methods</topic><topic>Medical sciences</topic><topic>Methicillin-Resistant Staphylococcus aureus - isolation & purification</topic><topic>Meticillin-resistant Staphylococcus aureus</topic><topic>Nose - microbiology</topic><topic>Nose, throat and perineum</topic><topic>Perineum - microbiology</topic><topic>Pharynx - microbiology</topic><topic>Prevalence</topic><topic>Program Evaluation</topic><topic>Staphylococcal Infections - diagnosis</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcal infections, streptococcal infections, pneumococcal infections</topic><topic>Staphylococcus aureus</topic><topic>Targeted approach</topic><topic>Universal screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Collins, J</creatorcontrib><creatorcontrib>Raza, M</creatorcontrib><creatorcontrib>Ford, M</creatorcontrib><creatorcontrib>Hall, L</creatorcontrib><creatorcontrib>Brydon, S</creatorcontrib><creatorcontrib>Gould, F.K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>The Journal of hospital infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Collins, J</au><au>Raza, M</au><au>Ford, M</au><au>Hall, L</au><au>Brydon, S</au><au>Gould, F.K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review of a three-year meticillin-resistant Staphylococcus aureus screening programme</atitle><jtitle>The Journal of hospital infection</jtitle><addtitle>J Hosp Infect</addtitle><date>2011-06-01</date><risdate>2011</risdate><volume>78</volume><issue>2</issue><spage>81</spage><epage>85</epage><pages>81-85</pages><issn>0195-6701</issn><eissn>1532-2939</eissn><abstract>Summary The Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH) implemented a seek and destroy (S&D) programme in 2006 to minimise meticillin-resistant Staphylococcus aureus (MRSA) colonisation and/or infection of patients. Using a phased introduction, all patient specialties were included in the scheme by September 2008, well in advance of the mandatory Department of Health, England (DoH) requirement for all patients to be screened. NuTH screens nose, throat and perineum samples from approximately 15 000 patients per month using a chromogenic culture method, showing a mean MRSA prevalence of 2.4%. Provision of seven-day microbiology and infection control services ensured that the turnaround time to prescribing decolonisation therapy was <24 h. Analysis of 168 073 results identified the necessity for inclusion of all three screening sites to maximise recovery of MRSA. Appraisal of the S&D policy demonstrated that MRSA detection rates did not increase despite an exponential increase in workload owing to mandatory inclusion of low risk areas in the screening programme. Review of data during a typical one-month period indicated that only seven day-case patients would not have been identified as MRSA carriers using our targeted S&D approach compared with the DoH universal screening. Detection of these additional patients incurred total laboratory costs of £20,000 and generated a further 4200 associated negative screens in one month alone. Our study indicates that a screening strategy based upon clinical risk is more pragmatic and more cost-effective than the universal programme currently required in England.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>21507518</pmid><doi>10.1016/j.jhin.2011.02.012</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0195-6701 |
| ispartof | The Journal of hospital infection, 2011-06, Vol.78 (2), p.81-85 |
| issn | 0195-6701 1532-2939 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_872138530 |
| source | ScienceDirect Freedom Collection 2022-2024 |
| subjects | Bacterial diseases Bacteriological Techniques Biological and medical sciences Carrier State - diagnosis Carrier State - epidemiology Carrier State - microbiology Chromogenic Compounds Culture Media England Hospitals, Teaching Human bacterial diseases Humans Infection Control - economics Infection Control - methods Infectious Disease Infectious diseases Mass Screening - economics Mass Screening - methods Medical sciences Methicillin-Resistant Staphylococcus aureus - isolation & purification Meticillin-resistant Staphylococcus aureus Nose - microbiology Nose, throat and perineum Perineum - microbiology Pharynx - microbiology Prevalence Program Evaluation Staphylococcal Infections - diagnosis Staphylococcal Infections - epidemiology Staphylococcal Infections - microbiology Staphylococcal infections, streptococcal infections, pneumococcal infections Staphylococcus aureus Targeted approach Universal screening |
| title | Review of a three-year meticillin-resistant Staphylococcus aureus screening programme |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T14%3A23%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20of%20a%20three-year%20meticillin-resistant%20Staphylococcus%20aureus%20screening%20programme&rft.jtitle=The%20Journal%20of%20hospital%20infection&rft.au=Collins,%20J&rft.date=2011-06-01&rft.volume=78&rft.issue=2&rft.spage=81&rft.epage=85&rft.pages=81-85&rft.issn=0195-6701&rft.eissn=1532-2939&rft_id=info:doi/10.1016/j.jhin.2011.02.012&rft_dat=%3Cproquest_cross%3E872138530%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c472t-bb4b46946256210d904bfe511d8f80223b1b1dcec19ff8172619f1ca4d36d0af3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=867725093&rft_id=info:pmid/21507518&rfr_iscdi=true |